Other

Foreign currency effect

Vertex Pharmaceuticals Foreign currency effect remained flat by 0.0% to $10.98M in Q4 2025 compared to the prior quarter.

Analysis

StatementIncome Statement
SectionOther
CategoryRisk
SignalContext dependent
VolatilityModerate
First reportedQ1 2023
Last reportedQ4 2025Feb 13, 2026

How to read this metric

This is primarily a mechanical accounting adjustment and does not necessarily reflect a change in tax strategy or risk.

Detailed definition

Reflects the impact of foreign currency exchange rate fluctuations on the valuation of unrecognized tax benefit liabilit...

Peer comparison

Standard adjustment line item in the tax footnote for multinational companies with global operations.

Metric ID: other_unrecognized_tax_benefits_increases_resulting_from_0e6d84

Historical Data

2 years
 FY'23FY'25
Value$300.00K$43.90M
YoY Change>999%
Range$300.00K$43.90M
Avg YoY Growth>999%
Median YoY Growth>999%

Frequently Asked Questions

What is Vertex Pharmaceuticals's foreign currency effect?
Vertex Pharmaceuticals (VRTX) reported foreign currency effect of $10.98M in Q4 2025.
What does foreign currency effect mean?
Changes in the value of tax liability reserves caused by shifts in foreign currency exchange rates.